Mission
To advance human justice and recovery through genetic truth, data-driven insights, and compassionate technology.
We want to transform the way addiction-related offenses are handled, shifting the focus from punishment to rehabilitation. NeuDefense delivers credible, science-driven solutions that support sentencing mitigation and long-term recovery.
Through advanced genetic testing, personalized neuro-nutrient therapy, and structured outpatient programs, we help courts, clinicians, and clients achieve better outcomes grounded in evidence and accountability.
Core Values
Scientific Integrity
We ground every service in validated research and clinical data, ensuring our programs meet the highest standards of medical and legal credibility.Personalized Justice
We believe legal outcomes should reflect individual biology and clinical need—not one-size-fits-all punishment.Lasting Recovery
Our model prioritizes sustainable sobriety, not short-term compliance, by integrating medical care, behavioral health, and biometric accountability.Innovation with Purpose
We harness genetic insight and therapeutic innovation to protect rights, preserve dignity, and improve public safety.Accountability & Advocacy
We empower clients to take ownership of their recovery while advocating for modern, humane alternatives to incarceration.
Meet the Team
Richard Paul Green III, BSBA, LCDC
Founder & Executive Director
Rick Green is a veteran executive and clinician with over 30 years of experience spanning addiction medicine, pharmaceutical innovation, forensic consulting, and legal strategy. He’s held leadership roles at Genzyme, Pfizer, Sanofi, and Geneus Health, and now serves as CEO of Precision Recovery, a top medically integrated rehab program supporting individuals facing felony DUI charges or licensing issues.
As a licensed chemical dependency counselor, Rick has delivered behavioral health services across outpatient, residential, and detox settings since 2014. He combines clinical expertise with a background in pharmaceutical development and has published on genetic addiction risk, dopamine regulation, and MAT policy. He frequently presents at national conferences and advises courts as an expert witness on forensic testing and substance use disorders.
Rick pioneered NeuDefense and co-developed Predict IQ the first genetic test used in DUI/SUD defense, marking a breakthrough in legal-health integration. He consults with attorneys, pharma companies, and treatment organizations, and has served on the NAADAC Public Policy Committee and other state-level advisory boards.
Expertise Highlights:
- CEO, Precision Recovery
- 30+ years in addiction, pharma, and legal-health innovation
- Licensed counselor and expert witness in DUI defense
- Creator of Predict IQ genetic legal tool
- Former executive at Genzyme, Pfizer, and Sanofi
- Advocate and educator in neuroscience-based recovery solutions
Our Clinical and Legal Team
Dr. Vidhya Narayanan, PhD
Genetic Director
Leads research and development, ensuring NeuDefense’s methods are scientifically sound and effective.
Maria Rodriguez, LCSW
Director of Rehabilitation
Oversees the Synapta+ program and outpatient treatment, ensuring personalized and effective recovery plans.
Jameson Davies
Lead Legal Strategist
Develops and implements legal strategies, leveraging genetic evidence to support clients’ defense.
Dr. James Jones, MD
Medical Advisor
Provides medical expertise and guidance, ensuring the safety and efficacy of NeuDefense’s treatment protocols.
